10329-98-3 Usage
Description
1-NAPHTHYL-N-ACETYL-BETA-D-GLUCOSAMINIDE is a chemical compound that belongs to the class of N-acetyl-beta-D-glucosaminides. It is characterized by the replacement of the anomeric hydroxy hydrogen with a 1-naphthyl group, which gives it unique properties and potential applications in various fields.
Uses
Used in Pharmaceutical Industry:
1-NAPHTHYL-N-ACETYL-BETA-D-GLUCOSAMINIDE is used as a pharmaceutical compound for its potential therapeutic applications. The presence of the 1-naphthyl group may allow for specific interactions with biological targets, making it a candidate for the development of new drugs or drug delivery systems.
Used in Chemical Research:
1-NAPHTHYL-N-ACETYL-BETA-D-GLUCOSAMINIDE can be used as a research tool in the field of chemistry, particularly in the study of carbohydrate chemistry and the development of new synthetic methods for the preparation of complex carbohydrate derivatives.
Used in Material Science:
The unique structure of 1-NAPHTHYL-N-ACETYL-BETA-D-GLUCOSAMINIDE may also find applications in material science, where it could be used to develop new materials with specific properties, such as improved biocompatibility or enhanced interaction with biological systems.
Check Digit Verification of cas no
The CAS Registry Mumber 10329-98-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,3,2 and 9 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 10329-98:
(7*1)+(6*0)+(5*3)+(4*2)+(3*9)+(2*9)+(1*8)=83
83 % 10 = 3
So 10329-98-3 is a valid CAS Registry Number.
10329-98-3Relevant articles and documents
Acceptor substrate-based selective inhibition of galactosyltransferases
Chung, Sang J.,Takayama, Shuichi,Wong, Chi-Huey
, p. 3359 - 3364 (1998)
This paper describes the discovery of glycosyl acceptor analogs as potent and selective inhibitors of α-1,3- and β-1,4- galactosyltransferases. Incorporation of an appropriate aromatic group to the aglycon position of the enzyme's acceptors results in a strong inhibition, representing the first and most potent small uncharged molecules as selective inhibitors of these two enzymes and thus providing a new strategy for the development of selective glycosyltransferase inhibitors.